ReviewHuman vaccines & immunotherapeutics2023

Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines.

Moe H Kyaw et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.